Background: The incidence of community-associated methicillin-resistant Staphylococcus aureus (MRSA) has risen dramatically in the U.S., particularly among children. Although Streptococcus pneumoniae colonization has been inversely associated with S. aureus colonization in unvaccinated children, this and other risk factors for S. aureus carriage have not been assessed following widespread use of the heptavalent pneumococcal conjugate vaccine (PCV7). Our objectives were to (1) determine the prevalence of S. aureus and MRSA colonization in young children in the context of widespread use of PCV7; and (2) examine risk factors for S. aureus colonization in the post-PCV7 era, including the absence of vaccine-type S. pneumoniae colonization.
Although absence of pneumococcal colonization was not significantly associated with S. aureus colonization, age (6) (7) (8) (9) (10) (11) 
Background
Infections due to Staphylococcus aureus are a growing clinical and public health problem in the US. [1] [2] [3] S. aureus can cause skin and soft tissue infections, pneumonia, bloodstream infections, and bone and joint infections in both children and adults. [4] [5] [6] [7] [8] [9] [10] [11] [12] Treatment of these infections has become more difficult in recent years due to the emergence and rapid spread of drug-resistant strains such as methicillin-resistant S. aureus (MRSA). Most troubling is the dramatic increase in community-associated MRSA (CA-MRSA) infections now being reported in healthy children and adults, but little is known about how patterns of colonization with S. aureus in the community have changed. [1, [13] [14] [15] Colonization of the anterior nares by S. aureus has been shown to be associated with subsequent infection in an individual. [16, 17] Furthermore, host and/or bacterial factors may increase this risk, such that a high fraction of colonized persons become infected. [18, 19] For example, a natural history study in a military population demonstrated that soft-tissue infections occurred more frequently after colonization with CA-MRSA in comparison to methicillin-susceptible S. aureus (38% vs. 3%). [18] Given the risk of infection associated with colonization, particularly with CA-MRSA strains, a greater understanding of the epidemiology of S. aureus colonization is needed in order to determine optimal control and prevention strategies.
Colonization with vaccine-type S. pneumoniae in the nasopharynx has been shown to be inversely associated with S. aureus nasal carriage in unvaccinated populations. [20, 21] This association is of particular concern given universal immunization with pneumococcal conjugate vaccine in the U.S. and the finding of replacement of vaccine serotypes with non-vaccine serotypes in the nasopharynx. [22] If vaccine serotypes do indeed interfere with colonization by S. aureus, use of PCV7 and the resulting removal of vaccine-type pneumococci from carriage may result in increased mucosal colonization with S. aureus.
Further elucidation of the epidemiology of S. aureus colonization in young children, particularly in vaccinated populations, and identification of risk factors for colonization is needed for the development of strategies for prevention in the community. In this article we take advantage of a unique opportunity to examine the prevalence and risk factors for S. aureus colonization in the context of an ongoing study of nasopharyngeal pneumococcal colonization among healthy children in Massachusetts. Our objectives were to: (1) determine the prevalence of S. aureus and MRSA colonization in healthy children in the post-PCV7 era and (2) examine risk factors for S. aureus colonization, including the absence of vaccine-type S. pneumoniae colonization.
Methods

Study Design and Population
We conducted a prospective observational study of S. aureus colonization among healthy children in Massachusetts. [23] This study was nested within an existing study to assess serial changes in S. pneumoniae serotypes and antibiotic resistance in the post-PCV7 era. [24] Children 6 years and younger who were seen for either well-child care visits or sick care visits in participating primary care practices were eligible for this study. Practices were selected from 16 communities in Massachusetts in 2003-04 and from 8 of these original 16 communities in 2006-07. Each participating child was sampled, at most, once during each swabbing season during 11/03-4/04 and 10/06-4/07. Written informed consent was obtained from parents. This study was approved by the Harvard Pilgrim Health Care Institutional Review Board.
Parents of enrolled children completed a written survey at the time of the visit that included information on age, gender, race/ethnicity, history of being breastfed, childcare attendance (>4 hours/week), smokers in the home, family members who work in a hospital or long-term care facility, recent antibiotic use, and history of chronic illness in children. Dates of immunization with PCV7 and influenza vaccines, diagnoses on day of visit, type of antibiotics received in the past 2 months, and patient zip code were obtained from medical record review. Because data on individual household income and educational level were not uniformly available, we used median census tract household income and educational level from the 2000 U.S. census based on geocoding address data.
Specimen Collection and Processing
Anterior nares swabs were collected by introducing a sterile calcium alginate-tipped swab on an aluminum shaft and gently rotating the swab. Swabs were transported by overnight courier and processed within 24 hours. Specimens were swabbed onto mannitol salt agar (MSA) plates where they were incubated at 37°C for 48 hours. Plates were examined for the presence of Mannitol-fermenting colonies daily and these were subcultured to trypticase soy agar and 5% sheep blood agar plates (BAPs) and incubated at 37°C overnight. Overnight cultures on BAPs were tested by catalase, Gram stain and Staphaurex (Remel, Lenexa, Kansas), a rapid latex-agglutination kit for identifying S. aureus. Catalase positive, Gram positive cocci which were negative by Staphaurex were tested for coagulase using rabbit plasma with EDTA. Catalase positive Gram-positive cocci in clusters which were positive in either the Staphaurex or coagulase tests were identified as S. aureus and underwent sensitivity testing by either disk diffusion or E-test for the following antibiotics: penicillin, oxacillin, erythromycin, clindamycin, trimethoprim/sulfamethoxazole, tetracycline, vancomycin, linezolid and mupirocin. For erythromycin-resistant, clindamycin-susceptible isolates, a D-test was also performed to determine the presence of erythromycin-inducible clindamycin resistance. S. aureus isolates were considered mupirocin resistant if the MIC was >4 μg/ml. [25] Isolation of S. pneumoniae from NP swabs, serotyping, and antimicrobial susceptibility testing were performed as described previously. [23] 
Data Analysis
We calculated the prevalence of S. aureus and MRSA colonization as a percentage with 95% confidence intervals. When assessing trends in S. aureus colonization over time, we compared the prevalence of colonization between 2003-04 and 2007-08 for the 8 communities participating in both sampling periods. To examine the relationship between S. pneumoniae and S. aureus co-colonization in individual children, we utilized data from all 16 communities. Categorical variables were compared using a chisquare test.
To assess risk factors for S. aureus colonization, multivariable logistic regression models were used. Clustering within communities was accounted for using generalized linear mixed models. [26, 27] Models of S. aureus colonization included the following variables: (1) year of swab, individual and community-level demographic characteristics, (2) S. pneumoniae colonization, (3) recent antibiotic use (within 2 months), (4) breastfeeding, (5) use of childcare outside the home, (6) diagnosis of illness on day of swab, (7) number of doses of PCV7 received, and (8) recent influenza vaccination. For the risk factor analyses, data from all available communities in each sampling period were used in our primary analyses. We also performed secondary analyses limited to the 8 communities surveyed in both periods. Because our results did not differ when analyses were limited to the 8 communities, results from our primary analyses are presented here. All analyses were performed using SAS version 9.1.3 (SAS Institute, Cary, NC).
Results
Study population
One thousand nine hundred sixty-eight children were enrolled in the study during 2003-04 and 2006-07, combined. The mean (SD) age of children was 2.7 (1.8) years with range of 0.3 to <7.0 years ( Table 1 ). Children were mostly white non-Hispanic (83.6%) and about half (53.2%) lived in communities where the median annual household income, based on U.S. census data for 2000, was less than $55,000. Children were enrolled in at least 4 hours of childcare per week (50.7%), had smokers in the home (19.9%), had a family member work in a hospital or long-term care facility (17.4%), received an antibiotic in the past 2 months (32.2%), received 3 or more doses of PCV7 vaccine (70.6%), and received influenza vaccine in the same season prior to their visit (24.0%). 29.1%, p < 0.001) among children enrolled in the study. No significant difference in colonization with S. aureus was noted among those children who were and were not colonized with S. pneumoniae. (12.4% vs. 15.5%; p = 0.10). To explore whether non-PCV7 carriage differentially affected S. aureus carriage, we further examined the proportion of people colonized with PCV7 strains vs. non-PCV7 strains compared to those who were not colonized with pneumococcus (Table 2 ). In children colonized with PCV7 or non-PCV7 strains, 11.4% and 12.7% were also colonized with S. aureus, respectively, compared to 15.5% for children who were not colonized with pneumococci (p = 0.29).
Staphylococcus aureus colonization
Risk factors for colonization
We examined risk factors for S. aureus colonization in children <7 years (Table 3 ). Bivariate analyses revealed that age had a U-shaped relationship with S. aureus colonization, with increased colonization among children <6 months and 5-<7 years. S. aureus colonization was lowest among children 1-<2 years of age. Use of antibiotics in the past 2 months was also associated with lower risk of S. aureus colonization. When the type of antibiotics used in the past 2 months was considered, we found that the inverse relationship with S. aureus colonization remained regardless of whether the antibiotic was very likely (amoxicillin-clavulanate, cephalosporins, mupirocin, trimethoprim-sulfamethoxazole), somewhat likely (clindamycin, macrolides), or unlikely (amoxicillin, penicillin) to have clinical activity against S. aureus.
In multivariable models, age and antibiotic use in the past 2 months remained significantly associated with S. aureus colonization when adjusted for other individual and community-level demographic characteristics and S. pneumoniae colonization (Table 4 ). Children 6 months-<1 year, 1-<2 years, 2-<3 years, and 3-<4 years of age were significantly less likely to be colonized with S. aureus compared to children 5 years and older. Also, children who recently received antibiotics in the past 2 months were less likely to be colonized with S. aureus. day of swab, pneumococcal colonization, number of doses of PCV7 vaccine, and recent influenza vaccination did not change the results of our model. Thus, we present the most parsimonious model in Table 4 . Because the number of MRSA isolates was small (N = 13) in our population, we did not examine risk factors for MRSA colonization.
Discussion
Between 2003-04 and 2006-07, S. aureus (15.3% to 14.1%) and MRSA (0.4% to 0.9%) colonization of the nares among children 3 months to <7 years remained stable in the setting of widespread use of the pneumococcal conjugate vaccine in Massachusetts and decreasing colonization with PCV7 strains. [28] Although S. aureus colonization was lower among children who were concomitantly colonized with S. pneumoniae, this relationship was modest and not statistically significant. Previous studies that found a negative association between these two species documented that the relationship was strongest when limited to S. pneumoniae serotypes included in the pneumococcal conjugate vaccine [20, 21, 29, 30] and when limited to MRSA. [29] The lack of statistical significance in our study may be due to the relative rarity of PCV7 serotypes among pneumococci and MRSA among S. aureus isolates in our population. However, a smaller proportion of isolates were susceptible to erythromycin and clindamycin in the latter season. Interestingly, antibiotic dispensing for broad-spectrum macrolides, such as clarithromycin and azithromycin, in a similar set of communities in Massachusetts has increased over a similar time period. [35] It is plausible that antibiotic pressure in these communities may have contributed to the emergence of strains such as USA300 with this particular antibiotic resistance phenotype. [36] [37] [38] In multivariate models, S. aureus colonization was found to be age-dependent in agreement with other published studies. [20, 32, 33, 39] Recent use of antibiotics was also found to be inversely associated with S. aureus colonization similar to prior studies. [39, 40] Although we found reduced S. aureus colonization following antibiotic use, we may only be seeing a transient decline in S. aureus colonization without fully understanding the longer-term impact of antibiotic use and the emergence of resistant organisms, since our study was cross-sectional in design. [41, 42] Furthermore, we found that colonization with S. aureus was lower in children regardless of the type of antibiotic used. This relationship is intriguing since we postulated that only antibiotics clinically active against S. aureus would be inversely associated with colonization as suggested by prior published studies. [39] One possibility is that recent antibiotic use is associated with another characteristic of these individuals that we were not able to measure. It may also be possible that part of the decline is due in part to 11% of the circulating S. aureus isolates in our population being susceptible to penicillins. The impact of recent antibiotic use on colonization patterns will be an important area for further study given concerns over the competitive balance between organisms in the nasopharynx. [43] .
There are several potential limitations to our study. First, we only included children less than 7 years of age, who may be at lower risk for MRSA colonization than older children. Second, we did not adequately assess all sites of colonization (e.g. skin, throat, rectum), thus underestimating the true prevalence of MRSA colonization, particularly since community-associated MRSA may be more likely than other MRSA or MSSA strains to colonize nonnasal sites.
[44] Third, we did not use an enrichment broth to isolate S. aureus or MRSA, which may have enhanced detection rates in other studies. Fourth, we only swabbed healthy children in Massachusetts, which is one of the last geographic areas to be hit by the CA-MRSA epidemic. [45] In contrast, significant increases in CA-MRSA disease and colonization have occurred in other parts of the country between 2003-04 and 2006-07. [11, 12, [31] [32] [33] [34] 37, [46] [47] [48] [49] Finally, we did not swab children longitudinally; thus, we were not able to assess whether these risk factors were different for children with transient vs. persistent S. aureus carriage. 
